60 Degrees Pharmaceuticals Statistics Share Statistics 60 Degrees Pharmaceuticals has 3.23M
shares outstanding. The number of shares has increased by -20.89%
in one year.
Shares Outstanding 3.23M Shares Change (YoY) -20.89% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 3.12M Failed to Deliver (FTD) Shares 8,120 FTD / Avg. Volume 1.29%
Short Selling Information The latest short interest is 466.93K, so 11.38% of the outstanding
shares have been sold short.
Short Interest 466.93K Short % of Shares Out 11.38% Short % of Float 11.46% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.37 and the forward
PE ratio is -0.26.
60 Degrees Pharmaceuticals's PEG ratio is
0.
PE Ratio -0.37 Forward PE -0.26 PS Ratio 4.83 Forward PS 2 PB Ratio 0.73 P/FCF Ratio -0.5 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for 60 Degrees Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.25,
with a Debt / Equity ratio of 0.04.
Current Ratio 3.25 Quick Ratio 2.98 Debt / Equity 0.04 Debt / EBITDA -0.02 Debt / FCF -0.03 Interest Coverage -1227.87
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $202.52K Profits Per Employee $-2.65M Employee Count 3 Asset Turnover 0.11 Inventory Turnover 0.87
Taxes Income Tax 250 Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -83.09% in the
last 52 weeks. The beta is 2.71, so 60 Degrees Pharmaceuticals's
price volatility has been higher than the market average.
Beta 2.71 52-Week Price Change -83.09% 50-Day Moving Average 2.06 200-Day Moving Average 3.33 Relative Strength Index (RSI) 37.19 Average Volume (20 Days) 631,450
Income Statement In the last 12 months, 60 Degrees Pharmaceuticals had revenue of 607.57K
and earned -7.95M
in profits. Earnings per share was -18.55.
Revenue 607.57K Gross Profit 222.81K Operating Income -9.71M Net Income -7.95M EBITDA -7.88M EBIT -7.95M Earnings Per Share (EPS) -18.55
Full Income Statement Balance Sheet The company has 1.66M in cash and 155.89K in
debt, giving a net cash position of 1.5M.
Cash & Cash Equivalents 1.66M Total Debt 155.89K Net Cash 1.5M Retained Earnings -40.53M Total Assets 5.98M Working Capital 3.85M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -5.65M
and capital expenditures -181.11K, giving a free cash flow of -5.83M.
Operating Cash Flow -5.65M Capital Expenditures -181.11K Free Cash Flow -5.83M FCF Per Share -12.82
Full Cash Flow Statement Margins Gross margin is 36.67%, with operating and profit margins of -1598.97% and -1308.01%.
Gross Margin 36.67% Operating Margin -1598.97% Pretax Margin -1309.37% Profit Margin -1308.01% EBITDA Margin -1297.58% EBIT Margin -1598.97% FCF Margin -959.42%
Dividends & Yields SXTP does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for SXTP is $7,
which is 410.9% higher than the current price. The consensus rating is "Buy".
Price Target $7 Price Target Difference 410.9% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Feb 24, 2025. It was a
backward
split with a ratio of 1:5.
Last Split Date Feb 24, 2025 Split Type backward Split Ratio 1:5
Scores Altman Z-Score -13.36 Piotroski F-Score 3
